SANDFORD D SMITH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SANDFORD D SMITH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is a Director in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in QLT INC/BC ($QLTI) and a Director in APRICUS BIOSCIENCES, INC. ($APRI) and a Director in CYTOKINETICS INC ($CYTK) and an Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Neuralstem, Inc. ($CUR) and a Director in AKCEA THERAPEUTICS, INC. ($AKCA).

Address: C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE 02139 MA

Companies in which SANDFORD D SMITH is an Insider

Aegerion Pharmaceuticals, Inc.

Trading Symbol: AEGR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Chief Executive Officer, Director
Holdings: 0 shares
Latest Transaction: Nov 30 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AKCEA THERAPEUTICS, INC.

Trading Symbol: AKCA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 0 shares
Latest Transaction: Oct 13 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ARIAD PHARMACEUTICALS INC

Trading Symbol: ARIA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SANDFORD D SMITH: Director
Holdings: 66,205 shares
Current Value: $1,576,341
Latest Transaction: Dec 01 2004
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CYTOKINETICS INC

Trading Symbol: CYTK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 5,920 shares
Current Value: $69,264
Latest Transaction: May 13 2021
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NOVELION THERAPEUTICS INC.

Trading Symbol: NVLN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 1,048 shares
Latest Transaction: Jan 31 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PALISADE BIO, INC.

Trading Symbol: SNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SANDFORD D SMITH: Director
Holdings: 219,916 shares
Current Value: $664,146
Latest Transaction: Jul 03 2019
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SEELOS THERAPEUTICS, INC.

Trading Symbol: SEEL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 16,160 shares
Current Value: $42,501
Latest Transaction: Jan 08 2018
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of SANDFORD D SMITH

Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorOption ExerciseA24.3210,000243,20010,000
May 13 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorGrantA0.005,00005,920920 to 5.9 K (+543.48 %)
Apr 27 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorOption ExerciseM10.685,00053,40015,000
Apr 27 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorOption ExerciseM10.554,73949,9960
Apr 27 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorSellS28.005,000140,0009205.9 K to 920 (-84.46 %)
Apr 27 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorBuyM10.685,00053,4005,920920 to 5.9 K (+543.48 %)
Apr 27 2021CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorSellS27.504,739130,3239205.7 K to 920 (-83.74 %)

View all SANDFORD D SMITH insider transactions.